C-Met immunoreactivity in operated stage I non-small cell lung cancer patients: Is it a prognostic marker?

Journal Title: Ege Tıp Dergisi - Year 2014, Vol 53, Issue 1

Abstract

Aim: In this study we evaluated the correlation between c-Met immunoreactivity and survival, thus the effect of hepatocyte growth factor (HGF) on prognosis, in operated early-stage non-small cell lung carcinoma (NSCLC) patients. Materials and Methods: Seventy patients who underwent resection for stage IA or IB NSCLC were examined retrospectively. Pathological preparations were evaluated to investigate c-Met immunoreactivity. Those with normal bronchial epithelium in the sections were used as positive control group and the sections of those who had not been stained by primary antibody were regarded as the negative control group. C-Met immunoreactivities were determined according to scores of staining. Results: There were no significant differences between c-Met immunoreactivity and clinicopathological factors. The analysis after exclusion of large cell carcinoma cases showed that c-Met immunoreactivity was higher in adenocarcinomas than in squamous cell carcinomas and the difference was statistically significant. Survival analysis to estimate the prognostic significance of c-Met immunoreactivity showed no significant differences for both diseasefree (p=0.499) and long-term survival (p=0.261). The difference between c-Met immunoreactivity and survival for the adenocarcinoma and squamous cell carcinoma groups was not significant. Conclusion: It seems that HGF expression and serum HGF levels appeared to be stronger prognostic markers than c-Met immunoreactivity for NSCLC, therefore detailed studies were needed regarding these prognostic factors.

Authors and Affiliations

A Ozdil, U Cagirici, K Turhan, A G Ergonul

Keywords

Related Articles

ESWL treatment results of 96 patients with proximal ureter stone

Aim: Extracorporeal shock wave lithotripsy (ESWL) is a favourable and succesful treatment method for ureter stones. It is highlighted that ESWL can be the first treatment choice for ureter stones. In this study, the resu...

Correlation of mid-trimester homocysteine, vitamin B12 and folate levels with adverse pregnancy outcomes: A clinical study

Aim: The aim of this study is to determine if maternal serum levels of folate, vitamin B12 and homocysteine at 20-26 weeks of gestation are associated with subsequent adverse pregnancy outcomes. Materials and Methods: Th...

Non-Alkolik nedenlere bağlı gelişen wernicke ensefalopatisinde manyetik rezonans görüntüleme bulguları

Amaç: Wernicke ensefalopatisi (WE) tiamin (vitamin B1) eksikliğine bağlı olarak gelişen nöropsikiyatrik bir hastalıktır. Sıklıkla kronik alkolizme bağlı olarak görülmekle birlikte tiamin alım veya emilim eksikliğine nede...

Very late development of coronary artery aneurysm with sirolimus eluting stent

Drug eluting stents (DES) are superior to bare metal stents except in patients scheduled surgery recently, high risk of bleeding and in patients cannot use long-term dual antiplatelet therapy. DESs are being used increas...

Efficacy of intravenous midazolam in dental implant surgery

Aim: The long-lasting procedure in dental implant surgery may impair a patient’s tolerance and make the working conditions for the surgeon difficult. The aim of this study was to explore the effect of administering consc...

Download PDF file
  • EP ID EP344869
  • DOI 10.19161/etd.344034
  • Views 110
  • Downloads 0

How To Cite

A Ozdil, U Cagirici, K Turhan, A G Ergonul (2014). C-Met immunoreactivity in operated stage I non-small cell lung cancer patients: Is it a prognostic marker?. Ege Tıp Dergisi, 53(1), 13-18. https://europub.co.uk/articles/-A-344869